Abstract:Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by the extracellular amyloid plaques in the brain. Recent studies have shown that ferroptosis, a recently identified cell death pathway associated with the accumulation of lipid hydroperoxides, is closely related to the occurrence and exacerbation of AD. The application of ferroptosis inhibitors can alleviate the development of AD in both cellular and animal models. Herein, a series of dual-functional hydroxylated chalcone derivatives by integrating the heterocyclic dimethylaminopyrimidine in the core structure were designed and synthesized beyond our previous research to optimize their inhibition activities towards A beta protein aggregation and ferroptosis simultaneously. The inhibitory ability of the novel synthesized chalcone derivatives were greatly improved. The results indicated that the introduction of the dimethylaminopyrimidine structure provided improved effect on A beta protein aggregation inhibitory activity in both solution and cellular models. Trihydroxy chalcone derivative A-N-5 provided the best inhibition activities against A beta protein aggregation in cellular models. The trihydroxy compound A-N-5 did not show cytotoxicity at the concentration lower than 100 mu M (with IC50 > 1 mM), but had a significant effect on promoting cell proliferation. Results indicated that compound A-N-5 could potentially promote neuronal cell growth in the damaged brain tissue. The compound could also inhibit ferroptosis induced by RSL or erastin and reduce the lipid peroxidation levels induced by A beta(1-42) protein aggregation. Molecular docking was also conducted to explain the better inhibitory effect of novel compounds to inhibit A beta protein aggregation compared to the previous designed molecules without incorporation of the dimethylaminopyrimidine. In summary, the trihydroxy compound A-N-5 showed the best inhibition activities against A beta aggregation as well as ferroptosis with low cytotoxicity as a promising molecular skeleton candidate for further development of lead compound for in vivo test to treat AD.

Synthesis and Evaluation of Multifunctional Ferulic and Caffeic Acid Dimers for Alzheimer'S Disease

Design, Synthesis and Biological Evaluation of 2-Styryl-5-hydroxy-4-pyrone Derivatives and Analogues As Multiple Functional Agents with the Potential for the Treatment of Alzheimer's Disease.

Novel 1-phenyl-3-hydroxy-4-pyridinone derivatives as Multifunctional Agents for the therapy of Alzheimer's Disease.

Design, synthesis and evaluation of novel ferulic acid derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease

Design, Synthesis, and Biological Evaluation of Scutellarein Carbamate Derivatives As Potential Multifunctional Agents for the Treatment of Alzheimer's Disease

Design, Synthesis, and Evaluation of Novel O-alkyl Ferulamide Derivatives As Multifunctional Ligands for Treating Alzheimer’s Disease

Design, Synthesis and Evaluation of Novel Tacrine-Ferulic Acid Hybrids As Multifunctional Drug Candidates Against Alzheimer’s Disease

Design, Synthesis and Evaluation of 4 '-Oh-flurbiprofen-chalcone Hybrids As Potential Multifunctional Agents for Alzheimer's Disease Treatment

Design, Synthesis and Evaluation of Novel Bivalent Β-Carboline Derivatives As Multifunctional Agents for the Treatment of Alzheimer's Disease.

Multifunctional Small Molecules as Potential Anti-Alzheimer’s Disease Agents

Design, Synthesis and Biological Evaluation of New Coumarin-Dithiocarbamate Hybrids As Multifunctional Agents for the Treatment of Alzheimer's Disease

Design, Synthesis, and Biological Evaluation of Curcumin Analogues As Multifunctional Agents for the Treatment of Alzheimer’s Disease

Syntheses and Evaluation of Asymmetric Curcumin Analogues As Potential Multifunctional Agents for the Treatment of Alzheimer’s Disease

Novel coumarin derivatives as multifunctional anti-AD agents: Design, synthesis, X-ray crystal structure and biological evaluation

Design, Synthesis and Biological Evaluation of Novel Carboline-Cinnamic Acid Hybrids As Multifunctional Agents for Treatment of Alzheimer's Disease.

Design, Synthesis and Biological Evaluation of Novel O-carbamoyl Ferulamide Derivatives As Multi-Target-directed Ligands for the Treatment of Alzheimer's Disease

Rational Design, Synthesis and Activities of Hydroxylated Chalcones As Highly Potent Dual Functional Agents Against Alzheimer's Disease.

Multifunctional Coumarin Derivatives: Monoamine Oxidase B (MAO-B) Inhibition, Anti-Β-amyloid (aβ) Aggregation and Metal Chelation Properties Against Alzheimer's Disease.

Design, Synthesis, and Biological Evaluation of Diosgenin-Indole Derivatives As Dual-Functional Agents for the Treatment of Alzheimer's Disease.

Tacrine-6-Ferulic Acid, a Novel Multifunctional Dimer, Inhibits Amyloid-β-Mediated Alzheimer's Disease-Associated Pathogenesis in Vitro and in Vivo

New Multi-Target-directed Small Molecules Against Alzheimer's Disease: a Combination of Resveratrol and Clioquinol.